Tour of New Zealand riders raise over $18k for NECNZ
Cyclists on the 2025 Tour of New Zealand raised more than $18,000 for Neuroendocrine Cancer NZ.
Watch the documentary of the 8th Tour of New Zealand – a 5-day cycle event in 2025 that raised funds and awareness for Neuroendocrine Cancer New Zealand. The video above opens at the NECNZ segment; rewind to the start for the full ride.
Riders on the 2025 Tour of New Zealand have raised more than $18,000 for Neuroendocrine Cancer New Zealand, with proceeds going directly toward patient information, peer support and advocacy for New Zealanders living with NETs.
We're enormously grateful to every rider, supporter and donor who got behind the tour. Funds like these are what keep our patient support work going year after year.
Related resources
More like this →
SCAN 2025: New Zealand leads on access, but patients still wait
New Zealanders with NETs rarely pay for treatment and have world-leading access to PRRT – but 59% report delays, and only 37% have heard of clinical trials. The SCAN 2025 findings, in full.
Honouring a legacy: Malcolm Legget MNZM
Associate Professor Dr Malcolm Legget was awarded the MNZM for services to neuroendocrine cancer care in New Zealand.
Waikato clinicians publish rare renal NET case in international oncology journal
A Waikato Hospital and University of Auckland team co-authored a 2025 case report on a renal neuroendocrine tumour causing Cushing's syndrome, published in Case Reports in Oncology.
Gallium-68 Dotatate PET-CT scans now accessible onboard Mobile Imaging
Mobile Health Group and Mercy Radiology have rolled out Gallium-68 Dotatate PET-CT scans on a mobile imaging unit, bringing advanced NET diagnostics closer to home.